Skip to main content
Peptide Intel Hub laboratory research video
Peptide Intel Hub

Protocols · Growth Hormone

CJC-1295 (no DAC) + Ipamorelin: literature-reported ranges

The rationale for pairing a GHRH analogue with a secretagogue is documented in pituitary physiology — the two act on different receptors and their combined effect on GH release is more than additive in published pharmacology. What does not exist is a controlled trial of this specific commercial blend.

Read this first

Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.

Compound at a glance

Class
GHRH analogue + selective ghrelin-receptor agonist blend
Reported half-life
Roughly 30 minutes and 2 hours respectively
Routes used in the literature
Subcutaneous
Also written as

What the published studies reported

Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.

GHRH + secretagogue co-administration pharmacology

Reported quantity
1 µg/kg GHRH analogue with 1 µg/kg secretagogue
Frequency
Single co-administration
Study duration
Sampling over 120 minutes

Synergy at the pituitary is well documented for the class, using research-grade GHRH rather than this blend.

Constituent figures, read separately

Reported quantity
Around 100 µg of each peptide per administration in reported multi-day designs
Frequency
One to three times daily
Study duration
Weeks

Blend vials rarely state the split; a combined milligram figure is not enough information.

Dosage chart

These figures match the published chart for this compound on peptidedosages.com, including the reconstitution volume, resulting concentration, insulin-syringe units and the staged schedule. Educational reference only — not instructions, and not medical advice.

CJC-1295 (no DAC) · 5 mg Vial

CJC-1295 NO DAC is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. This information is for research and educational use only.

Reconstitute
Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.
Typical daily range
100–300 mcg once daily (gradual titration).
Easy measuring
At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.
Storage
Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within 1–2 weeks; for longer storage, freeze at ≤−20 °C (≤−4 °F).

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2100 mcg6 units (0.06 mL)
Weeks 3–4150 mcg9 units (0.09 mL)
Weeks 5–6200 mcg12 units (0.12 mL)
Weeks 7–12250–300 mcg15–18 units (0.15–0.18 mL)
Source chart on peptidedosages.com

Ipamorelin · 10 mg Vial

Ipamorelin is dosed at 100 mcg–250 mcg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

Reconstitute
Add 3.0 mL bacteriostatic water → ~ 3.33 mg/mL concentration.
Typical daily range
100–300 mcg once daily (gradual titration recommended).
Easy measuring
At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33 mcg on a U-100 insulin syringe.
Storage
Lyophilized: 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within ~4 weeks.

Standard / Gradual Approach (3.0 mL = ~3.33 mg/mL)

WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2100 mcg3 units (0.03 mL)
Weeks 3–4150 mcg5 units (0.05 mL)
Weeks 5–8200 mcg6 units (0.06 mL)
Weeks 9–12250 mcg8 units (0.08 mL)
Source chart on peptidedosages.com

Mixed with 3 ml of bacteriostatic water

The same arithmetic for every vial size CJC-1295 (no DAC) + Ipamorelin is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.

CJC-1295 (no DAC) + Ipamorelin · 3 ml bacteriostatic water

Vial sizeConcentrationPer 1 unit100 mcg =300 mcg =
10 mg3.33 mg/ml33 mcg3.0 units9.0 units

Unit columns use the range reported for this compound (100 mcg–300 mcg). Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.

Reconstitution maths

A blend vial stating 10 mg total in 2 mL gives 5 mg/mL of combined peptide. Ask for the per-peptide mass on the certificate before treating that as two 2.5 mg/mL solutions.

Open the reconstitution calculator

How to read these figures

  • Two peptides means two identity and purity assays — a single combined figure hides under-filling of the more expensive component.
  • Class synergy evidence does not validate any particular commercial ratio.
  • Non-DAC blends require frequent administration because both components clear quickly.

Sources and citations

No peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.

Search the databases yourself

Read the CJC-1295 (no DAC) + Ipamorelin research brief

Other growth hormone compounds

All research protocols

Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.

Share
© 2026 Peptide Intel Hub · Marbella · Educational research reference · For in-vitro research use only
Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.